Integrating non-clinical and clinical evidence for prioritisation in paediatric oncology drug development: Regulatory experience with three PARP inhibitors

EMC - Otorinolaringoiatria · Elsevier

Аннотация

Publication date: December 2026 Source: EJC Paediatric Oncology, Volume 8 Author(s): Karen Van Malderen, Sofie Peirs, Evelyne Pirotte, Caoimhin G. Concannon, Fabien Lavergne, Pauliina Lehtolainen-Dalkilic, Anne Miermont, Peter van Meer, Maria E. Sheean, Dominik Karres

Читать у издателя →

Похожие статьи